Raman spectroscopy was assessed for its ability to rapidly identify asbestos phases by submitting the amphiboles anthophyllite, amosite, crocidolite and tremolite to spectroscopic analysis. All the phases were characterized by using XRD, SEM, TEM (CTEM, SAED), AEM and EDS techniques. This study demonstrates that accurate identification of the mineralogical phase can be attained by analysing the position in the Raman spectrum of the bands corresponding to the symmetric stretching modes (v_s) and to the antisymmetric stretching modes (v_as) of the different Si—O linkages. Raman spectroscopy thus proves to be an effective technique for rapidly distinguishing the different fibrous minerals examined.

There are six elongate mineral particles (EMPs) corresponding to specific dimensional and morphological criteria, known as asbestos. Responsible for health issues including asbestosis, and malignant mesothelioma, asbestos has been well researched. Despite this, significant exposure continues to occur throughout the world, potentially affecting 125 million people in the workplace and causing thousands of deaths annually from exposure in homes. However, there are other EMPS, such as fibrous/asbestiform erionite, that are classified as carcinogens and have been linked to cancers in areas where it has been incorporated into local building materials or released into the environment through earthmoving activities. Erionite is a more potent carcinogen than asbestos but as it is seldom used for commercial purposes, exposure pathways have been less well studied. Despite the apparent similarities between asbestos and fibrous erionite, their health risks and exposure pathways are quite different. This article examines the hazards presented by EMPs with a particular focus on fibrous erionite. It includes a discussion of the global locations of erionite and similar hazardous minerals, a comparison of the multiple exposure pathways for asbestos and fibrous erionite, a brief discussion of the confusing nomenclature associated with EMPs, and considerations of increasing global mesothelioma cases.